Dr. Nabil Y Khawand, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 6228 Oxon Hill Rd, Oxon Hill, MD 20745 Phone: 301-839-0770 Fax: 301-839-1350 |
Abraham Farivari, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 6228 Oxon Hill Rd, Oxon Hill, MD 20745 Phone: 301-839-0334 Fax: 301-749-8788 |
Dr. Othman Ahmad Baban, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 6228 Oxon Hill Rd, Oxon Hill, MD 20745 Phone: 301-839-0770 Fax: 301-839-1350 |
News Archive
To guarantee a high quality of their beer, breweries monitor the production process very closely. With a new polymer powder, this monitoring will be able to be faster and simpler in the future.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced commencement of a Phase 2 study of a d-Amphetamine Transdermal System (d-ATS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Currently, there is no approved amphetamine-based transdermal treatment option available for ADHD.
Biofilms-mats of bacteria similar to the plaque that grows on teeth-frequently coat the surfaces of catheters, and of various medical implants and prostheses, where they can threaten lives or lead to failure of the implants. Antibiotics are impotent against biofilms.
EarlySense announced today that its EverOn Central Display Station (CDS) has been cleared for marketing by the U.S. Food and Drug Administration (FDA). The FDA clearance covers the ability of the system to collect real time vital sign information from up to 36 EverOn bedside monitors and display the information on a computer screen at the nurse's station.
› Verified 2 days ago